Informacja

Drogi użytkowniku, aplikacja do prawidłowego działania wymaga obsługi JavaScript. Proszę włącz obsługę JavaScript w Twojej przeglądarce.

Wyszukujesz frazę ""McCrary Sisk, Christine"" wg kryterium: Autor


Wyświetlanie 1-16 z 16
Tytuł:
Effects of anacetrapib on plasma lipids in specific patient subgroups in the DEFINE (Determining the Efficacy and Tolerability of CETP INhibition with AnacEtrapib) trial
Autorzy:
Gerstman, M.
Howes, L.
Kostner, K.
Nestel, P.
Sullivan, D.
Brath, H.
Patsch, J.
Paulweber, B.
Toplak, H.
Constance, C.M.
Howlett, E.
Mymin, D.
Pliamm, L.
Saunders, K.K.
Tardif, J.-C.
Tytus, R.
Aschner, P.
Keinänen-Klukaanniemi, S.
Strandberg, T.
Taskinen, M.-R.
Luc, G.
Richter, D.
Schlienger, J.L.
Zaïr, Y.
Appel, K.-F.
Baar, M.
Luley, C.
Overhoff, U.
Pomykaj, T.
Schaefer, T.
Lau, S.T.
Lee, K.L.F.
Tan, K.
Tomlinson, B.
Tsang, M.W.
Badacsonyi, K.
Kalina, Á.
Kanakaridisz, N.
Márk, L.
Péterfai, É.
Regos, L.
Reiber, I.
Takács, J.
Vértes, A.
Elis, A.
Gavish, D.
Harats, D.
Hussein, O.
Hayek, T.
Leitersdorf, E.
Bin Abdul Ghapar, A.K.
Chee, K.H.
Ismail, S.B.
Ling, K.H.
Ramanathan, G.R.L.
Sim, K.H.
Alvarado, R.
Benavides, M.
Cardona, G.E.
Gonzalez, G.
Verdejo, J.
Basart, D.C.G.
Imholz, B.P.M.
Jonker, J.J.C.
Nierop, P.R.
Posma, J.L.
Twickler, Th.B.
Barrington-Ward, E.
Cutfield, R.
Friedlander, D.H.
Scott, R.S.
Istad, H.
Langslet, G.
Skjelvan, G.K.
Campodónico Hoyos, S.J.
Coloma Araniya, R.
Gallegos C., A.
Pino Morales, C.A.
Watanabe, L.
Arutyunov, G.P.
Blokhin, A.B.
Bubnova, M.G.
Marcevich, S.Y.
Álvarez Sánchez, C.
Álvarez-Sala Walther, L.A.
Gil Extremera, B.
Perez Jimenez, F.
de Teresa Parreño, L.
Anderberg, C.-P.
Hedin, U.
Hellberg, A.
Höök, P.
Kjellström, T.
Nilsson, P.
Olsson, A.G.
Rosenqvist, U.
Tolagen, K.
Wolff, T.
Baskin, A.
Bays, H.E.
Bernstein, R.I.
Bittar, N.
Brinton, E.A.
Chee, L.H.K.
Cottiero, R.A.
D'Agostino, R.D.
Davidson, M.H.
Denker, P.S.
Garcia, R.K.
Hippert, R.K.
Isakov, T.
Kaster, S.R.
Kerzner, B.
Klein, E.J.
Koren, M.J.
Kutner, M.E.
Liljenquist, D.
Lorch, D.G., Jr.
Lorraine, R.
Lubin, B.C.
Lunde, N.M.
Majchrzak, T.J.
McKenney, J.M.
Mukherjee, S.
Muse, D.D.
Otruba, M.S.
Pappas, J.E.
Patrick, K.
Powell, S.J.
Riffer, E.
Rink, L.D.
Rohlf, J.L.
Rosen, J.B.
Rosenbilt, P.D.
Roth, E.M.
Rubenstein, C.J.
Rubino, J.
Rudolph, L.A.
Schneider, A.
Short, W.G.
Silverfield, J.C.
Suresh, D.P.
Tarshis, G.A.
Toth, P.D.
Townsend, R.W.
Wahl, T.O.
Brinton, Eliot A.
Kher, Uma
Shah, Sukrut
Cannon, Christopher P.
Davidson, Michael
Gotto, Antonio M.
Ashraf, Tanya B.
McCrary Sisk, Christine
Dansky, Hayes
Mitchel, Yale
Barter, Philip
Pokaż więcej
Źródło:
In Journal of Clinical Lipidology January-February 2015 9(1):65-71
Czasopismo naukowe
Tytuł:
Impact of patient characteristics on the pharmacokinetics of corifollitropin alfa during controlled ovarian stimulation.
Autorzy:
Zandvliet, Anthe S.
Prohn, Marita
Greef, Rik
Aarle, Frank
McCrary Sisk, Christine
Stegmann, Barbara J.
Pokaż więcej
Temat:
FOLLICLE-stimulating hormone
PHARMACOKINETICS
DRUG dosage
BODY mass index
BODY weight
MULTILEVEL models
Źródło:
British Journal of Clinical Pharmacology; Jul2016, Vol. 82 Issue 1, p74-82, 9p, 1 Diagram, 4 Charts, 4 Graphs
Czasopismo naukowe
Tytuł:
Effects of anacetrapib on plasma lipids in specific patient subgroups in the DEFINE (Determining the Efficacy and Tolerability of CETP INhibition with AnacEtrapib) trial.
Autorzy:
Brinton, Eliot A.
Kher, Uma
Shah, Sukrut
Cannon, Christopher P.
Davidson, Michael
Gotto, Antonio M.
Ashraf, Tanya B.
McCrary Sisk, Christine
Dansky, Hayes
Mitchel, Yale
Barter, Philip
Pokaż więcej
Temat:
COMBINATION drug therapy
HYPERLIPIDEMIA
RACE
DATA analysis software
DESCRIPTIVE statistics
INVESTIGATIONAL drugs
PREVENTION
Źródło:
Journal of Clinical Lipidology; Jan2015, Vol. 9 Issue 1, p65-71, 7p
Czasopismo naukowe
Tytuł:
Effects of extended-release niacin/laropiprant, simvastatin, and the combination on correlations between apolipoprotein B, LDLcholesterol, and non-HDLcholesterol in patients with dyslipidemia.
Autorzy:
Farnier, Michel
Chen, Erluo
Johnson-Levonas, Amy O.
McCrary Sisk, Christine
Mitchel, Yale B.
Pokaż więcej
Temat:
APOLIPOPROTEIN B
LOW density lipoproteins
CHOLESTEROL
NIACIN
SIMVASTATIN
DYSLIPIDEMIA
Źródło:
Vascular Health & Risk Management; 2014, Vol. 10, p279-290, 12p
Czasopismo naukowe
Tytuł:
Effects of extended release niacin/laropiprant, laropiprant, extended release niacin and placebo on platelet aggregation and bleeding time in healthy subjects.
Autorzy:
Lai, Eseng
Schwartz, Jules I.
Dallob, Aimee
Jumes, Patricia
Liu, Fang
Kraft, Walter K.
Royalty, Jane
Chodakewitz, Jeffrey A.
Mccrary Sisk, Christine
Radziszewski, Waldemar
Wagner, John A.
Pokaż więcej
Temat:
NIACIN
PLACEBOS
HEMORRHAGE
BLOOD platelets
CONNECTIVE tissues
Źródło:
Platelets; May2010, Vol. 21 Issue 3, p191-198, 8p, 1 Chart, 2 Graphs
Czasopismo naukowe
Tytuł:
Lipid-modifying efficacy of extended release niacin/laropiprant in Asian patients with primary hypercholesterolemia or mixed hyperlipidemia.
Autorzy:
Kush, Debra
Kim, Hyo-Soo
Hu, Da Yi
Liu, Ji
Sirah, Waheeda
Sapre, Aditi
McCrary Sisk, Christine
Paolini, John F.
Maccubbin, Darbie
Pokaż więcej
Temat:
NIACIN
DRUG efficacy
CONTROLLED release drugs
HYPERCHOLESTEREMIA
HYPERLIPIDEMIA
CARDIOVASCULAR system
PROSTAGLANDINS
DRUG tablets
PATIENTS
Źródło:
Journal of Clinical Lipidology; May2009, Vol. 3 Issue 3, p179-186, 8p
Terminy geograficzne:
ASIA
Czasopismo naukowe
Tytuł:
An open-label clinical trial to investigate the efficacy and safety of corifollitropin alfa combined with hCG in adult men with hypogonadotropic hypogonadism.
Autorzy:
Nieschlag E; University Hospital of Muenster, Center of Reproductive Medicine and Andrology, Domagkstraße 11, D-48149, Muenster, Germany. .
Bouloux PG; The Royal Free Hospital, Pond St, London, NW3 2QG, UK.
Stegmann BJ; Merck & Co., Inc., 2000 Galloping Hill Road, Kenilworth, NJ, 07033, USA.
Shankar RR; Merck & Co., Inc., 2000 Galloping Hill Road, Kenilworth, NJ, 07033, USA.
Guan Y; Merck & Co., Inc., 2000 Galloping Hill Road, Kenilworth, NJ, 07033, USA.
Tzontcheva A; Merck & Co., Inc., 2000 Galloping Hill Road, Kenilworth, NJ, 07033, USA.
McCrary Sisk C; Merck & Co., Inc., 2000 Galloping Hill Road, Kenilworth, NJ, 07033, USA.
Behre HM; University Hospital Halle (Saale), Martin Luther University Halle-Wittenberg, Ernst-Grube-Str. 40, D-06120, Halle, Germany.
Pokaż więcej
Źródło:
Reproductive biology and endocrinology : RB&E [Reprod Biol Endocrinol] 2017 Mar 07; Vol. 15 (1), pp. 17. Date of Electronic Publication: 2017 Mar 07.
Typ publikacji:
Clinical Trial, Phase III; Journal Article; Multicenter Study
MeSH Terms:
Azoospermia/*drug therapy
Chorionic Gonadotropin/*therapeutic use
Follicle Stimulating Hormone, Human/*therapeutic use
Hypogonadism/*drug therapy
Adult ; Azoospermia/complications ; Drug Administration Schedule ; Humans ; Hypogonadism/complications ; Male ; Middle Aged ; Organ Size/drug effects ; Spermatogenesis/drug effects ; Testis/drug effects ; Testis/pathology ; Treatment Outcome ; Young Adult
Czasopismo naukowe
Tytuł:
Losartan and enalapril are comparable in reducing proteinuria in children with Alport syndrome.
Autorzy:
Webb NJ; Department of Paediatric Nephrology and Wellcome Trust Children's Clinical Research Facility, Manchester Academic Health Science Centre, Royal Manchester Children's Hospital, The University of Manchester, Manchester, UK. />Shahinfar S
Wells TG
Massaad R
Gleim GW
McCrary Sisk C
Lam C
Pokaż więcej
Źródło:
Pediatric nephrology (Berlin, Germany) [Pediatr Nephrol] 2013 May; Vol. 28 (5), pp. 737-43. Date of Electronic Publication: 2012 Dec 04.
Typ publikacji:
Comparative Study; Journal Article; Multicenter Study; Randomized Controlled Trial; Research Support, Non-U.S. Gov't
MeSH Terms:
Angiotensin-Converting Enzyme Inhibitors/*therapeutic use
Enalapril/*therapeutic use
Kidney/*drug effects
Losartan/*therapeutic use
Nephritis, Hereditary/*drug therapy
Proteinuria/*drug therapy
Adolescent ; Angiotensin II Type 1 Receptor Blockers/adverse effects ; Angiotensin II Type 1 Receptor Blockers/therapeutic use ; Angiotensin-Converting Enzyme Inhibitors/adverse effects ; Asia ; Biomarkers/urine ; Child ; Child, Preschool ; Creatinine/urine ; Double-Blind Method ; Enalapril/adverse effects ; Europe ; Female ; Glomerular Filtration Rate/drug effects ; Humans ; Infant ; Kidney/physiopathology ; Least-Squares Analysis ; Losartan/adverse effects ; Male ; Nephritis, Hereditary/complications ; Nephritis, Hereditary/diagnosis ; Nephritis, Hereditary/physiopathology ; Nephritis, Hereditary/urine ; Proteinuria/diagnosis ; Proteinuria/etiology ; Proteinuria/physiopathology ; Proteinuria/urine ; South America ; Time Factors ; Treatment Outcome ; United States
Czasopismo naukowe
    Wyświetlanie 1-16 z 16

    Ta witryna wykorzystuje pliki cookies do przechowywania informacji na Twoim komputerze. Pliki cookies stosujemy w celu świadczenia usług na najwyższym poziomie, w tym w sposób dostosowany do indywidualnych potrzeb. Korzystanie z witryny bez zmiany ustawień dotyczących cookies oznacza, że będą one zamieszczane w Twoim komputerze. W każdym momencie możesz dokonać zmiany ustawień dotyczących cookies